Skip to main content
Clinical Trials/JPRN-UMIN000002029
JPRN-UMIN000002029
Completed
Phase 2

A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2) - A phase II trial of definitive chemoradiotherapy (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2)

Kitasato University School of Medicine0 sites35 target enrollmentJune 1, 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
locally advanced esophageal carcinoma
Sponsor
Kitasato University School of Medicine
Enrollment
35
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2009
End Date
December 31, 2013
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kitasato University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. History of serious drug hypersensitivity 2\. Active gastrointestinal bleeding 3\. Active infection 4\. Severe complication (interstitial pneumonia or pulmonary fibrosis, poorly controlled diabetes mellitus, heart failure, renal failure, liver cirrhosis or etc) 5\. Active synchronous or metachronous malignancy other than carcinoma in situ. 6\. Mental disorders being treated with antipsychotic agents or requiring treatment 7\. Pregnant or lactation women, or women with the possibility of the pregnancy 8\. Men who want let to pregnancy 9\. Patients who are judged inappropriate for the entry into the study by the investigater

Outcomes

Primary Outcomes

Not specified

Similar Trials